KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Net Income (2016 - 2025)

Opko Health (OPK) has disclosed Net Income for 16 consecutive years, with -$46.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income fell 260.66% year-over-year to -$46.2 million, compared with a TTM value of -$240.6 million through Dec 2025, down 525.67%, and an annual FY2025 reading of -$240.6 million, down 525.68% over the prior year.
  • Net Income was -$46.2 million for Q4 2025 at Opko Health, down from $21.6 million in the prior quarter.
  • Across five years, Net Income topped out at $31.1 million in Q1 2021 and bottomed at -$159.6 million in Q4 2022.
  • Average Net Income over 5 years is -$45.0 million, with a median of -$50.8 million recorded in 2022.
  • The sharpest move saw Net Income soared 152.75% in 2021, then tumbled 1340.62% in 2025.
  • Year by year, Net Income stood at -$73.3 million in 2021, then plummeted by 117.72% to -$159.6 million in 2022, then soared by 58.44% to -$66.3 million in 2023, then skyrocketed by 143.39% to $28.8 million in 2024, then plummeted by 260.66% to -$46.2 million in 2025.
  • Business Quant data shows Net Income for OPK at -$46.2 million in Q4 2025, $21.6 million in Q3 2025, and -$148.4 million in Q2 2025.